5-CL-ADB-A

5-CL-ADB-A: An Overview of a Synthetic Cannabinoid

5-CL-ADB-A, also known as MDMB-4en-PINACA, is a synthetic cannabinoid belonging to the class of indazole-3-carboxylic acid amide derivatives. It was first identified in Europe in 2017 and is structurally close to other known synthetic Cannabinoids 5F-MDMB-PINACA.

Chemical structure and properties

The chemical structure of 5-CL-ADB-A comprises an indazole base structure connected to a carboxylic acid amide side chain. A characteristic feature is the introduction of a chlorine group at the fifth position of the pentyl radical, giving it its name. This modification affects the affinity of the molecule to the cannabinoid receptor CB1 and can enhance its psychoactive effect.

Use and occurrence

5-CL-ADB-A was mainly sold as part of "herbal mixtures" or "spice" products available over the Internet. These products are often advertised as legal alternatives to cannabis, although their safety and legality are questionable. The substance has been detected in confiscated samples in various countries, including Germany.

Risks and health effects

Like many synthetic cannabinoids, 5-CL-ADB-A can pose significant health risks. Reports of acute intoxications and adverse effects such as hallucinations, anxiety and circulatory problems have been documented. In some cases, deaths related to the use of such substances have also been noted.

Legal situation

The legal classification of 5-CL-ADB-A varies by country. In many European countries, including Germany, it falls under the Narcotics Act and is therefore illegal. Nevertheless, due to its structure and impact, it remains an issue of supervision and regulation in some regions.

Conclusion

5CL-ADB-A is a synthetic cannabinoid with a potent effect on the CB1 receptor system. It is important to be aware of the dangers and to avoid the consumption of such substances.